PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Feb-2024 Tesla Continues Reign of Top Shorted Security in January, Finds Hazeltree Shortside Crowdedness Report Businesswire
14-Feb-2024 BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering Businesswire
14-Feb-2024 Cybin Reports Third Quarter Financial Results and Recent Business Highlights Businesswire
14-Feb-2024 JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders Businesswire
14-Feb-2024 United States Ammonia Crackers Industry Research Report 2023-2032 Featuring Key Players - Lindberg/MPH, Gasbarre Products, AMOGY, and Thermal Dynamix - A Judd Service Company - ResearchAndMarkets.com Businesswire
14-Feb-2024 Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness Businesswire
14-Feb-2024 Antibe Reports Q3 2024 Interim Financial and Operating Results Businesswire
14-Feb-2024 NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management Businesswire
14-Feb-2024 Benson Hill Announces Chief Financial Officer Transition Businesswire
14-Feb-2024 IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance Businesswire
14-Feb-2024 Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance Businesswire
14-Feb-2024 Satellos to Commence Trading on the Toronto Stock Exchange Businesswire
14-Feb-2024 U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Augtyro™ (repotrectinib) for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors Businesswire
14-Feb-2024 CORRECTING and REPLACING, Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU Businesswire
14-Feb-2024 United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024 Businesswire
14-Feb-2024 The Sustained Power of Aplantex’s Strategic Game Plan Is Confirmed by the Securing of $ 3.3 M in Second-Round Financing Businesswire
14-Feb-2024 Freudenberg Medical establishes second production facility in Costa Rica Businesswire
14-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Feb-2024 Medscape Global Launches Innovative Programmatic Offering Setting a New Standard in Targeted HCP Engagement in the United Kingdom, European Union and Canada Businesswire
14-Feb-2024 uMed helps Queen Mary University of London and University College London move closer to understanding Parkinson’s risk factors as first-of-its-kind study exceeds 10,000 participant milestone uMed